|
Novosense are involved in
the following research projects:
Three-dimensional nanobiostructure-based self-contained devices for
biomedical application
Novosense is developing a
3D-based self contained biomedical devices consisting of a glucose/oxygen
sensor, a biofuel cell and a wireless signal transmitter to demonstrate
wireless monitoring of glucose and oxygen in biological fluids, wounds, and
cell cultures. The implant consist of;
The implant is powered by the glucose and oxygen in the
body fluid that is used by a fuel cell. The fuel cell typically delivers a
current in the range of microA with only 0.5 Volt, which is to little to
drive any electronics. The current is harvested and when enough energy is
stored the radio module is powered up which sample the sensors and then
transmit the information to a nearby base station. One of the big challenges
has been to construct the energy-harvesting module which operates with this
low voltage and current.
The project is sponsored by the European Commission.
Acronym: 3D-nanobiodevice
Grant Agreement Number: 229255
Call identifier: FP7-NMP-2008-SMALL-2
Coordinator: Sergey Shleeve
 
Back to top
Biomedical Wireless
Sensor Network – phase II
The BWSN 2 Consortium project partners were from Sweden: Millicore,
Novosense
and
Imego.
From Norway
Memscap,
Novelda
and the
Interventional
Centre at
Oslo University
Hospital. From
Finland
VTT
also continued. New project partners were
Delta
from Denmark, and
SINTEF
from Norway.
Overall project objective was to use a biomedical wireless
sensor network as a basis for collaboration on product and services
opportunities. Sensor integration solutions was to be made on a commercial
platform in a common communication specification and protocol. The platform
was tested and verified in a clinical user environment. Read more in
About BWSN-2
and the first
BWSN Project
This project was supported by; Nordisk Innovation Center,
medCoast, Nutek and Innovation Norge. The project was classed as a eureka
project.
    
Back to top
Sensor Radio Technology
Novosense
has developed products using Bluetooth and Zigbee Radio technology in
numerous application fields but mainly for medical products. Application
using minimum of power, long operation and/or high throughput application
with high synchronisation demands.
Novosense is currently working on integration of Ultra
Wideband Impulse Radio (UWB-IR) technology with the companies ECG sensors.
The radio technology has a very low power consumption, which would increase
the ECG sensors operational life span and reducing the size of the sensor.
The radio technology is designed to apply with worldwide standards defining
the range of allowable/available frequencies (FCC: 3.1GHz to 10.6GHz, ETSI:
6.0GHz to 8.5GHz). The high bandwidth allows for disturbance free
coexistence of several transceivers and thus supports many sensors at a high
data rate operating in close vicinity. Furthermore the UWB-band is today
unoccupied as there are basically no radios on the market utilising the UWB
frequencies. Taking the high bandwidth, the low frequency utilisation and
the appliance to worldwide standards into account, the UWB radio solution
has significant advantage compared to competing telemetry systems.
Research is supported by:
VINNOVA – Eurostars program, E!5274, NextGenECG
Tillväxtverket – A Swedish-Norwegian program to increase
cooperation in industry, ID 145592
 
Back to top
|
